Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tilray Brands Inc
(NQ:
TLRY
)
1.310
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tilray Brands Inc
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?
November 21, 2024
Medical cannabis users still represent less than 0.3% of the population, indicating significant potential for market expansion.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
November 21, 2024
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56.
Via
Benzinga
Topics
Cannabis
ETFs
Government
Exposures
Cannabis
Political
Redhook Brewery and Montlake Futures Team Up to Launch Montlake Gameday Gold Lager, a New Craft Beer in Support of University of Washington Athletes
November 21, 2024
From
Tilray Brands, Inc.
Via
GlobeNewswire
How Is The Market Feeling About Tilray Brands?
November 19, 2024
Via
Benzinga
Tilray Brands Unveils 2024 Holiday Cannabis Gift Guide
November 21, 2024
Indulge in Premium Chocolate Edibles, Cannabis-Infused Drinks, New Pre-Rolls, and Top-Quality Flower - the Perfect Selection for Cannabis Connoisseurs this Festive Season!
From
Tilray Brands, Inc.
Via
GlobeNewswire
Tilray Brands Gets Festive with its 2024 Holiday Beverage Gift Guide
November 21, 2024
From
Tilray Brands, Inc.
Via
GlobeNewswire
Prediction: Tilray Brands Won't Be a Cannabis Company in 5 Years
November 20, 2024
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
These 2 Marijuana Stocks Could Surge Under Trump's Second Term
November 20, 2024
Via
The Motley Fool
Topics
Cannabis
Government
Exposures
Cannabis
Political
Beverages, Alcohol and Tobacco Stocks Q3 Recap: Benchmarking Tilray Brands (NASDAQ:TLRY)
November 20, 2024
Looking back on beverages, alcohol and tobacco stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Tilray Brands (NASDAQ:TLRY) and its peers.
Via
StockStory
Topics
Cannabis
Exposures
Cannabis
Q3 Earnings Outperformers: Celsius (NASDAQ:CELH) And The Rest Of The Beverages, Alcohol and Tobacco Stocks
November 19, 2024
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Celsius (NASDAQ:CELH) and the best and worst...
Via
StockStory
Topics
Cannabis
Exposures
Cannabis
Shareholder Lawsuit Challenges Tilray's Voting Tactics For Authorized Share Increase
November 15, 2024
Tilray faces a new shareholder lawsuit accusing the company of misleading voting practices, following a $39.9M settlement over similar issues
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Tilray Joins German Cannabis Fiesta With First Locally Grown Strains
November 14, 2024
Tilray Medical launches its first German-grown cannabis products under a new cultivation license, tapping into Germany's expanding market...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
CBD Pioneer Charlotte's Web Narrows Loss In Q3, Focuses On Long-Term Growth
November 14, 2024
Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) a producer of hemp-derived CBD and other botanical wellness products, reported on Thursday financial results for the third quarter ended Sept....
Via
Benzinga
Blue Point Brewery Expands Winter Seasonal Lineup with Blitz Beer American Lager and Hosts The Blue Point Blitz Celebration at Webster Hall
November 14, 2024
From
Tilray Brands, Inc.
Via
GlobeNewswire
Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License
November 14, 2024
From
Tilray Brands, Inc.
Via
GlobeNewswire
Get Ready for Winter with 10 Barrel’s 13th Annual Pray for Snow Party
November 13, 2024
Join 10 Barrel Brewing for a Free Community Event Celebrating the Snowboard Season with Live Music, Giveaways, and the Premiere of the "Beer Lodge" film at 10 Barrel’s Winter Party
From
Tilray Brands, Inc.
Via
GlobeNewswire
Breckenridge Distillery's Latest Creation is the Perfect Addition to Your Holiday Bar: Breckenridge Candy Cane Vodka
November 13, 2024
From
Tilray Brands, Inc.
Via
GlobeNewswire
Does the Rejection of Top Marijuana Legalization Measures Doom the Pot Industry?
November 13, 2024
The American electorate seems to have turned against weed legal reform.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
420 with CNW — German Marijuana Club Hands Out Legal Cannabis as Pilot Program Kicks Off
November 12, 2024
Via
CannabisNewsWire
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis
November 12, 2024
Cannabis stocks rally on prediction of Trump descheduling marijuana; MSOS leads gains with a 15% surge, followed by Cronos at nearly 13%.
Via
Benzinga
Topics
Cannabis
Government
Exposures
Cannabis
Political
Experience the Ultimate 420 Festival Celebration with SweetWater's 20th Anniversary Lineup Featuring The Revivalists, Marcus King Band, Greensky Bluegrass, Drive-By Truckers and Cypress Hill at Atlanta's Iconic Pullman Yards from April 18-20, 2025
November 12, 2024
From
Tilray Brands, Inc.
Via
GlobeNewswire
Cannabis Stocks: Is It Time To Buy The Dip After Elections And Legalization Setbacks?
November 07, 2024
After a post-election plunge, cannabis stocks are showing signs of recovery. We analyze Tilray, SNDL, Trulieve, MSOS – time to buy the dip?
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Aurora vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?
November 07, 2024
Aurora's international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Extract Significantly Reduces Chemotherapy-Induced Vomiting, Tilray-Backed Study Reveals
November 07, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Tilray Launches "Men's Health on Tap" Podcast: Acclaimed Doctors Engage in Empowering Discussions and Break Down Stigmas Around Men's Health Topics
November 07, 2024
From
Tilray Brands, Inc.
Via
GlobeNewswire
Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis
November 07, 2024
From
Tilray Brands, Inc.
Via
GlobeNewswire
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
November 06, 2024
Following Trump's presidential election victory, the cannabis sector took a sharp downturn. Here's a summary of what happened today.
Via
Benzinga
Topics
Cannabis
Government
Exposures
Cannabis
Political
Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty
November 06, 2024
Cannabis stocks plunge as Florida's legalization fails and GOP Senate control tempers expectations for industry growth.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Tilray, High Tide, Glass House: How Top Cannabis Companies Deal With Financial Pressures
November 01, 2024
Discover how cannabis stocks like Tilray, High Tide, and Glass House adapt strategies amid election uncertainty and market volatility.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
420 with CNW — Scientific Review Finds Marijuana Lowers Chronic Nerve Pain
October 31, 2024
Via
CannabisNewsWire
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.